Publisher |
American Chemical Society (ACS) |
Agreement ID | acs2024heal |
Agreement labeling | ACS Read and Publish Agreement |
Has the agreement been disclosed and published? | Yes |
URL | https://diavgeia.gov.gr/doc/6ΕΝΨ46Ψ8ΧΒ-1Γ4 |
Agreement period | 01/01/2024 – 12/31/2024 |
Consortia / Institution | HEAL-Link (Hellenic Academic Libraries Link) |
Country | Greece |
SIZE
Approximate range of annual corresponding author publications |
106 |
Comments on size/article output | 106 articles published in 2022 by HEAL-Link members |
COSTS
How do the costs of the agreement relate to previous subscription-only agreements with the publisher? |
Cost increase |
Comments on cost development | Cost increase includes an upgrade to all ACS journal publications |
FINANCIAL SHIFT
Transformative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard? |
Subscriptions partly converted to OA publishing fees |
RISK SHARING
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements? |
Capped agreement. 94 hybrid and gold OA articles are covered in 2024, slightly below annual publishing output. |
OA COVERAGE
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement? |
Yes |
Are fully open access journals covered by the agreement? | Yes |
OA LICENSE | CC-BY |
ARTICLE TYPES |
All article types except for additions, corrections, editorials |
ACCESS COSTS
What is the approximate share of access related costs of the overall agreement? |
More than 50% |
Comments on access costs | Clear distinction between reading costs and OA publishing costs |
ACCESS COVERAGE
Are all read relevant journals covered by the agreement? |
Yes |
PERPETUAL ACCESS RIGHTS | Yes |
WORKFLOW ASSESSMENT | Too early to assess |
Comments on workflows | It is the first RAP agreement with the publisher |
OVERALL ASSESSMENT AND COMMENTS | Too early to assess |
Request contact to the licensee | contact@esac-initiative.org |